0 2 An an DT 3 7 IL-2 il-2 NN 8 16 response response NN 17 24 element element NN 25 27 in in IN 28 31 the the DT 32 37 human human JJ 38 42 IL-2 il-2 NN 43 51 receptor receptor NN 52 57 alpha alpha NN 58 63 chain chain NN 64 72 promoter promoter NN 73 75 is be VBZ 76 77 a a DT 78 87 composite composite JJ 88 95 element element NN 96 100 that that WDT 101 106 binds bind VBZ 107 112 Stat5 Stat5 NNP 112 113 , , , 114 119 Elf-1 Elf-1 NNP 119 120 , , , 121 129 HMG-I(Y) HMG-I(Y) NNP 130 133 and and CC 134 135 a a DT 136 140 GATA GATA NNP 141 147 family family NN 148 155 protein protein NN 155 156 . . . 158 168 Expression expression NN 169 171 of of IN 172 175 the the DT 176 181 human human JJ 182 195 interleukin-2 interleukin-2 NN 196 197 ( ( ( 197 201 IL-2 il-2 NN 201 202 ) ) ) 203 211 receptor receptor NN 212 217 alpha alpha NN 218 223 chain chain NN 224 228 gene gene NN 229 231 is be VBZ 232 240 potently potently RB 241 252 upregulated upregulate VBN 253 255 by by IN 256 259 its its PRP$ 260 263 own own JJ 264 270 ligand ligand NN 270 271 , , , 272 276 IL-2 il-2 NN 276 277 . . . 278 280 In in IN 281 285 this this DT 286 291 study study NN 291 292 , , , 293 295 we we PRP 296 308 characterize characterize VBP 309 311 an an DT 312 321 essential essential JJ 322 330 upstream upstream JJ 331 335 IL-2 il-2 NN 336 344 response response NN 345 352 element element NN 353 357 that that WDT 358 366 contains contain VBZ 367 371 both both CC 372 381 consensus consensus NN 382 385 and and CC 386 399 non-consensus non-consensus JJ 400 403 GAS GAS NNP 404 410 motifs motif NNS 410 411 , , , 412 415 two two CD 416 424 putative putative JJ 425 428 Ets ets NN 429 436 binding binding NN 437 442 sites site NNS 443 444 ( ( ( 444 447 EBS EBS NNP 447 448 ) ) ) 448 449 , , , 450 453 one one CD 454 456 of of IN 457 462 which which WDT 463 471 overlaps overlap VBZ 472 475 the the DT 476 485 consensus consensus NN 486 489 GAS GAS NNP 490 495 motif motif NN 495 496 , , , 497 500 and and CC 501 502 a a DT 503 507 GATA GATA NNP 508 513 motif motif NN 513 514 , , , 515 520 which which WDT 521 529 overlaps overlap VBZ 530 533 the the DT 534 547 non-consensus non-consensus JJ 548 551 GAS GAS NNP 552 557 motif motif NN 557 558 . . . 559 561 We we PRP 562 573 demonstrate demonstrate VBP 574 578 that that IN 579 587 although although IN 588 591 the the DT 592 602 individual individual JJ 603 613 components component NNS 614 616 of of IN 617 621 this this DT 622 629 element element NN 630 632 do do VBP 633 636 not not RB 637 644 respond respond VB 645 647 to to TO 648 652 IL-2 il-2 NN 652 653 , , , 654 662 together together RB 663 667 they they PRP 668 672 form form VBP 673 674 a a DT 675 684 composite composite JJ 685 692 element element NN 693 700 capable capable JJ 701 703 of of IN 704 714 conferring confer VBG 715 719 IL-2 il-2 NN 720 734 responsiveness responsiveness NN 735 737 to to TO 738 739 a a DT 740 752 heterologous heterologous JJ 753 761 promoter promoter NN 761 762 . . . 763 771 Multiple multiple JJ 772 779 factors factor NNS 780 789 including include VBG 790 795 Stat5 Stat5 NNP 795 796 , , , 797 802 Elf-1 Elf-1 NNP 802 803 , , , 804 812 HMG-I(Y) HMG-I(Y) NNP 813 816 and and CC 817 821 GATA GATA NNP 822 828 family family NN 829 837 proteins protein NNS 838 842 bind bind VBP 843 845 to to TO 846 849 the the DT 850 854 IL-2 il-2 NN 855 863 response response NN 864 871 element element NN 872 875 and and CC 876 884 mutation mutation NN 885 887 of of IN 888 891 any any DT 892 895 one one CD 896 898 of of IN 899 904 these these DT 905 912 binding bind VBG 913 918 sites site NNS 919 929 diminishes diminish VBZ 930 933 the the DT 934 942 activity activity NN 943 945 of of IN 946 950 this this DT 951 958 element element NN 958 959 . . . 960 962 An an DT 963 975 unidentified unidentified JJ 976 979 Ets Ets NNP 980 986 family family NN 987 994 protein protein NN 995 1000 binds bind VBZ 1001 1003 to to TO 1004 1007 the the DT 1008 1011 EBS ebs NN 1012 1023 overlapping overlap VBG 1024 1027 the the DT 1028 1037 consensus consensus NN 1038 1041 GAS GAS NNP 1042 1047 motif motif NN 1048 1051 and and CC 1052 1059 appears appear VBZ 1060 1062 to to TO 1063 1073 negatively negatively RB 1074 1082 regulate regulate VB 1083 1086 the the DT 1087 1092 human human JJ 1093 1098 IL-2R il-2r NN 1099 1104 alpha alpha NN 1105 1113 promoter promoter NN 1113 1114 . . . 1115 1119 Thus thus RB 1119 1120 , , , 1121 1133 IL-2-induced il-2-induced JJ 1134 1139 IL-2R IL-2R NNP 1140 1145 alpha alpha NN 1146 1154 promoter promoter NN 1155 1163 activity activity NN 1164 1172 requires require VBZ 1173 1174 a a DT 1175 1182 complex complex JJ 1183 1191 upstream upstream JJ 1192 1199 element element NN 1199 1200 , , , 1201 1206 which which WDT 1207 1214 appears appear VBZ 1215 1217 to to TO 1218 1225 contain contain VB 1226 1233 binding bind VBG 1234 1239 sites site NNS 1240 1243 for for IN 1244 1248 both both CC 1249 1257 positive positive JJ 1258 1261 and and CC 1262 1270 negative negative JJ 1271 1281 regulatory regulatory JJ 1282 1289 factors factor NNS 1289 1290 . . .